Skip to main content
. 1997 Mar 18;94(6):2489–2494. doi: 10.1073/pnas.94.6.2489

Figure 1.

Figure 1

Tumor therapy and toxicity with C215Fab–SEA (Fab–SEA) and mutated C215Fab–SEA D227A (Fab–SEA D227A) in TCR Vβ3 TG mice. Reduction of pulmonary B16-C215 metastases are recorded after three injections of Fab–SEA proteins on a daily basis starting 1 day after tumor injection. Toxicity was noted after the third injection of Fab–SEA or Fab–SEA D227A in tumor-bearing TCR Vβ3 TG mice. Presented data represents the mean of three to four different experiments with six to eight animals in each experimental group.